Strong and weak hydrogen bonds in protein-ligand complexes of kinases: A comparative study

Amino Acids

Volumn 34, Issue 4, 2008, Pages 617-633

  Panigrahi, Sunil K ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Hydrogen bond; Kinase; Protein Data Bank; Supramolecular synthon; Water

Indexed keywords

ADENYLATE KINASE; BRUTON TYROSINE KINASE; CHECKPOINT KINASE 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 5; CYTIDYLMONOPHOSPHATE KINASE; DEATH ASSOCIATED PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCEROL KINASE; HEMATOPOIETIC CELL KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; NUCLEOSIDE DIPHOSPHATE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOGLYCERATE KINASE; PHOSPHOINOSITIDE 3 KINASE GAMMA; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; POLO LIKE KINASE 1; PROTEIN KINASE; PROTEIN KINASE C IOTA; PROTEIN KINASE LCK; PROTEIN KINASE PIM 1; THYMIDINE KINASE; THYMIDYLATE KINASE; UNINDEXED DRUG; URIDINE CYTIDINE KINASE 2;

ARTICLE; BINDING SITE; COMPARATIVE STUDY; ENZYME INHIBITION; EUKARYOTE; HUMAN; HYDROGEN BOND; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN DATA BANK; SEQUENCE ANALYSIS; SUPRAMOLECULAR CHEMISTRY; X RAY CRYSTALLOGRAPHY;

ADENOSINE TRIPHOSPHATE; AMINO ACIDS; ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DATABASES, FACTUAL; EUKARYOTIC CELLS; HUMANS; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; PROKARYOTIC CELLS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; REPRODUCIBILITY OF RESULTS; STRUCTURE-ACTIVITY RELATIONSHIP; WATER;

EUKARYOTA; PROKARYOTA;

EID: 43149115877     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-007-0015-4     Document Type: Article

References (44)

1. Aparna V, Rambabu G, Panigrahi SK, Sarma JARP, Desiraju GR (2005) Virtual screening of 4-anilinoquinazoline analogs as EGFR kinase inhibitors: importance of hydrogen bonds in the evaluation of poses and scoring functions. J Chem Inf Model 45:725-738
2. Auffinger P, Hays FA, Westhof E, Ho PS (2004) Halogen bonds in biological molecules. Proc Natl Acad Sci USA 101:16789-16794
3. Baker EN, Hubbard RE (1984) Hydrogen bonding in globular proteins. Progr Biophys Mol Biol 44:97-179
4. Bartlett GJ, Porter CT, Borkakoti N, Thornton JM (2002) Analysis of catalytic residues in enzyme active sites. J Mol Biol 324:105-121
5. Bikadi Z, Demko L, Hazai E (2007) Functional and structural characterization of a protein based on analysis of its hydrogen bonding network by hydrogen bonding plot. Arch Biochem Biophys 461:225-234
6. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank Nucleic Acid Res 28:235-242. http://www.rcsb.org/pdb
7. Brandl M, Weiss MS, Jabs A, Sühnel J, Hilgenfeld R (2001) C-H⋯π interactions in proteins. J Mol Biol 307:357-377
8. Bridges AJ (2001) Chemical inhibitors of protein kinases. Chem Rev 101:2541-2571
9. Bottoms CA, Smith PE, Tanner JJ (2002) Protein Sci 11:2125-2137
10. Cohen P (2002) Protein kinases-the major drug targets of the twenty-first century. Nature Rev Drug Discov 1:309-315
11. Dar AC, Wybenga-Groot LE, Sicheri F (2005) The eukaryotic protein kinase domain. In: Cesareni G, Gimona M, Sudol M, Yaffe M (eds) Modular protein domains, chap 9. Wiley-VCH, Verlag GmbH & Co, KGaA
12. Desiraju GR, Steiner T (1999) The weak hydrogen bond in structural chemistry and biology, chaps 1 and 5. Oxford University Press, Oxford
13. Desiraju GR (1995) Supramolecular synthons in crystal engineerings A-new organic synthesis. Angew Chem Int Ed 34:2311-2327
14. Denessiouk KA, Johnson MS (2003) "Acceptor-donor-acceptor" motifs recognize the watson-crick, hoogsteen and sugar "donor-acceptor- donor" edges of adenine and adenosinecontaining ligands. J Mol Biol 333:1025-1043
15. Gitlin I, Carbeck JD, Whitesides GM (2006) Why are proteins charged? Networks of charge-charge interactions in proteins measured by charge ladders and capillary electrophoresis. Angew Chem Int Ed 45:3022-3060
16. Glusker JP (1995) Intermolecular interactions around functional groups in crystals: data for modeling the binding of drugs to biological macromolecules. Acta Cryst D51:418-427
17. Halgren T (1996) Merck molecular force field. I. Basis, form, scope, parameterisation and performance of MMFF94. J Comput Chem 17:490-519
18. Hanks SK, Hunter T (1995) Protein kinases the eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9:576-596
19. Higgins D, Thompson J, Gibson T, Thompson JD, Higgins DG, Gibson TJ (1994) Nucleic Acids Res 22:4673-4680. ClustalW WWW Service at the European Bioinformatics Institute http://www.ebi.ac.uk/clustalw
20. Jeffrey GA, Saenger W (1991) Hydrogen bonding in biological structures. Springer, Berlin
21. Klaholz B, Moras D (2002) C-H⋯O hydrogen bonds in the nuclear receptor RARγ-a potential tool for drug selectivity. Structure 10:1197-1204
22. Koellner G, Steiner T, Millard CB, Silman I, Sussman JL (2002) A neutral molecule in a cation-binding site: specific binding of a PEG-SH to acetylcholinesterase from Torpedo californica. J Mol Biol 320:721-725
23. Ladbury JE (1996) Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem Biol 3:973-980
24. Lipinski CA, Lombardo F, Dominy BW, Feeney PL (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25
25. Levitzki A (2003) Protein kinase inhibitors as a therapeutic modality. Acc Chem Res 36:462-469
26. Mao L, Wang Y, Lie Y, Hu X (2004) Molecular determinants for ATP-binding in proteins: a data mining and quantum chemical analysis. J Mol Biol 336:787-807
27. MOE Program, Version 2006-08 Chemical Computing Inc, Sherbrooke St. W, Montreal, Quebec, Canada, H3A 2R7
28. Naumann T, Matter H (2002) Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. J Med Chem 45:2366-2378
29. Panigrahi SK, Desiraju GR (2007) Strong and weak hydrogen bonds in the protein-ligand interface. Proteins 67:128-141
30. Panigrahi SK, Desiraju GR (2004) Homology modelling in protein structure prediction: epidermal growth factor receptor kinase domain. Nat Acad Sci Lett (India) 27:1-11
31. Pierce AC, Sandretto KL, Bemis GW (2002) Kinase inhibitors and the case for CH⋯O hydrogen bonds in protein-ligand binding. Proteins 49:567-576
32. Pierce AC, ter Haar E, Binch HM, Kay DP, Patel SR, Li P (2005) CH⋯O and CH⋯N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor. J Med Chem 48:1278-1281
33. Sarkhel S, Desiraju GR (2004) N-H⋯O, O-H⋯O, and C-H⋯O hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition. Proteins 54:247-259
34. Steiner T (2002) The hydrogen bond in the solid state. Angew Chem Int Ed 41:48-76
35. Sugen (2002) Structure and Phylogeny of the Protein Kinases, Salk Institute, La Jolla, CA. http://198.202.68.14/human/kinome/phylogeny.html and http://kinasedb.ontology.ims.u-tokyo.ac.jp
36. The Protein Kinase Resource, SDSC, UC, San Diego, MC, 2004, http://www.kinasenet.org/pkr
37. Tiwari A, Panigrahi SK (2007) HBAT: a complete package for analysing strong and weak hydrogen bonds in macromolecular crystal structures. In Silico Biol 7:0057
38. Vishweshwar P, Nangia A, Lynch VM (2003) Molecular complexes of homologous alkanedicarboxylic acids with isonicotinamide: X-ray crystal structures, hydrogen bond synthons, and melting point alternation. Cryst Growth Des 3:783-790
39. Vieth M, Higgs RE, Robertson DH, Shapiro M, Gragg EA, Hemmerle H (2004) Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. Biochim Biophys Acta 1697:243-257
40. Wang R, Fang X, Lu Y, Yang CY, Wang S (2005) The PDBbind database: methodologies and updates J Med Chem 48:4111-4119. http://www.pdbbind.org
41. Walsh RDB, Bradner MW, Fleischman S, Morales LA, Moulton B, Rodríguez-Hornedo N, Zaworotko M (2003) Crystal engineering of the composition of pharmaceutical phases. J Chem Commun 2:186-187. doi: 10.1039/b208574g
42. Williams DH, Mitchell T (2002) Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates, Curr Opin Pharmacol 2:567-573
43. Williams MA, Goodfellow JM, Thornton JM (1994) Buried waters and internal cavities in monomeric proteins. Protein Sci 3:1224-1235
44. Wilhelm S, Carter C, Lynch M., Lowinger T, Dumas J, Smith RA, Schwartz B., Simantov R, Kelley S (2006) Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 5:835-844